Per the program's published design paper (Giblin et al., Diabetes, Obesity and Metabolism , 2026), the core registrational program consists of four trials : TRIUMPH-1 (NCT05929066): 80-week weight management basket trial, adults with obesity/overweight without diabetes (N=2,339), with knee osteoarthritis and obstructive sleep apnea substudies nested inside it
Acad Bras Cienc (2009) 81(3):34565
If you are considering treatment and want to know whether you qualify first, you can complete the free assessment quiz before starting
: People taking semaglutide may be at increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), which can lead to blindness
doi: 10.3803/EnM.2021.1293
However, the difference in weight loss outcomes between sites is typically modestthe dose strength and your personal metabolic response matter far more than whether you choose your abdomen or thigh